Cannabis part of the future says tobacco giant
British American Tobacco said it wanted to "accelerate" its transformation by reducing the health impact of its products.In March, BAT took a stake in Canadian medical cannabis maker Organigram. It also signed a deal to research a new range of adult cannabis products, initially focused on cannabidiol (CBD).
"As we think about our portfolio for the future, certainly beyond nicotine products are interesting for us as another wave of future growth," BAT executive Kingsley Wheaton told Radio 4's Today Programme.
==================================================
High profile: Cannabis chemical delta-8 gains fans, scrutiny
A chemical cousin of pot’s main intoxicating ingredient has rocketed to popularity over the last year, and the cannabis industry and state governments are scrambling to reckon with it amid debate over whether it’s legal.The 2018 federal law that OK’d hemp products said they couldn’t be more than 0.3% delta-9, but it said nothing about delta-8.
Enthusiasts interpret that silence as a green light for delta-8, and some officials also see an opening for it.
Last edited: